Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
... that allows users to combine positron
emission
tomography (PET), single photon emission computed tomography
(SPECT) and computed
tomography (CT) acquisition systems in one unit. The
system ... three
PET*CT or single photon emission computed
tomography and CT (SPECT*CT)
studies simultaneously. Using ...
Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
... advanced state-of-the-art diagnostic and therapeutic services including administration of chemotherapy, biologic and targeted therapies, Computed
tomography (CT), Intensity Modulated Radiation Therapy (IMRT), laboratory and pharmacy services, and an extensive clinical trials program connecting patients to ...
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
... Medical Inc.
VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular
tomography (FMT (TM) ) Imaging Systems, provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of ...
Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
... an intermediate term (mean of 7.7 years) follow-up. Bone mineral density adjacent to acetabular implants was evaluated using quantitative computed
tomography (QCT). The data demonstrated that stress-shielding around standard titanium cementless acetabular components continues well beyond the short-term. ...
vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque
... variety of imaging techniques: multi-slice CT, intravascular ultrasound (IVUS), IVUS-virtual histology (IVUS-VH), angiography, and optical coherence
tomography (OCT). Additional details on the SECRITT I study methodology can be found in a case study published recently in Nature Reviews Cardiology (vol. 6, ...
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
... stent program was presented by Robert Cottone, vice president of intellectual property and technologies. Angiographic and optical coherence
tomography (OCT) imagery were reviewed illustrating the new stent platform's deliverability, design features, and vessel scaffolding. "The nature of the ...
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
... of the system. Other key endpoints of the study include imaging assessments by angiography, intravascular ultrasound (IVUS), optical coherence
tomography (OCT), and other state-of-the-art invasive and non-invasive imaging modalities at six months, one year and two years.
Abbott's bioabsorbable ...
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
... death.
Bioabsorption of the stent at two years after implantation, as confirmed by an assessment of the stent struts using optical coherence
tomography (OCT).
Restoration of vasomotion (ability of the blood vessel to contract and expand) was observed at two years, with the drug acetylcholine ...
Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
... 101 percutaneous cryoablations on 91 patients who either couldn't undergo surgery or elected the interventional radiology treatment. Using computed
tomography (CT) imaging, researchers could view tumors and probes in real time. Interventional cryoablation "has an excellent safety profile," said Georgiades. ...
Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
... the dopamine transporter (DAT) protein found on the surface of dopamine-producing neurons, making it visible during Single Photon Emission Computed
tomography or "SPECT" imaging. Since most forms of Parkinsonian Syndromes result in a decreased number of dopamine-producing cells, it would be expected that ...
Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research
... the blockage can be sticky and adhere to the wall of the artery, making it difficult to break up, said Dr. Hopkins.
Researchers used computed
tomography (CT) perfusion to determine if the use of a stent would be beneficial. "With CT perfusion we can tell if the brain is dead or alive," said Dr. ...
Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
... incremental amounts of D2 receptor and serotonin reuptake transporter (SERT) occupancy. This has been confirmed in an ongoing human Positron Emission
tomography (PET) study where we have demonstrated that this dose is associated with measurable brain dopamine D2 receptor occupancy (see below).
These ...
MRI Emerges As Vital Resource in Treatment of Back Pain
... diseases of the spinal cord, nerve roots, vertebrae, disks and blood vessels. With MRI there is no radiation risk to the patient.
Computed
tomography (CT) has also improved in resolution and scanning speed and is often the only imaging method available for patients with pacemakers, nerve ...
Portable CT Increases Chance of Stroke Survival and Recovery
... CHICAGO, Dec. 2 /PRNewswire-USNewswire/ -- New research has found that the availability of a portable eight-slice computed
tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment. Results of ...
New Mammography Technology Effective in Detecting Breast Cancer
... high-risk patients.
In the study, 208 patients with breast cancer underwent PEM, an application of high-resolution breast positron emission
tomography (PET) in which a small amount of radioactive material is injected into the body to measure metabolic activity and determine the presence of disease. ...
VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
... of patients
in the ACS trial continued for an additional 12 weeks of treatment at the
same dose followed by a 64 slice multi-detector computed
tomography (MDCT)
scan following up on the baseline MDCT scan that all patients had received.
The statistical outcomes for the ACS trial were validated by an ...
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
... after stent implantation and at 6-month follow-up.
Further analysis of 1,904 cross sections (19,028 struts) by investigators
using Optimal Coherence
tomography at baseline and again at 6-month
follow-up in a subset of 15 randomly selected patients revealed complete
endothelialization and 99.5 percent stent ...
FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents
... FluoroPharma's founder and Chief Scientific Advisor,
will report on two preclinical studies demonstrating the potential of novel
Positron Emission
tomography (PET) molecular imaging agents for detection
of Alzheimer's disease (AD) and prostate cancer at the World Molecular
Imaging Congress, in Nice, France ...
September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
... called dual energy X-ray imaging, goes beyond the
single perspective image of an X-ray exam or the multiple perspectives of a
computerized
tomography (CT) scan. Dual energy X-ray imaging can identify
the compositions of substances and tissues in the body. Images can be
differentiated that would be ...
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
... functional measurement (FM) consoles and single-use
pressure and flow guide wires and is developing a line of ultra-high
resolution Optical Coherence
tomography (OCT) and Forward Looking IVUS
systems and catheters. Currently, more than 3,500 Volcano IVUS and FM
systems are installed worldwide, with ...
Are PET Scans Beneficial During Cancer Diagnosis, Staging and Monitoring?
... Independent Review Organization (IRO). http://www.allmedmd.com
According to Freedman, an oncologist usually combines a PET scan with
computed
tomography (CT) to capture higher resolution pictures of a
patient's tissue. Because the PET images are low-resolution, oncologists
combine the two to increase ...
Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
... metastatic or unresectable
RCC had to have disease progression after being treated with at least one
prior regimen of systemic therapy. Computed
tomography (CT) scan
documentation of disease progression following the most recent therapy was
required. Talactoferrin was administered at a dose of 1.5 grams ...
Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
... that improve the safety and
productivity of health care, today announced that it will now manufacture,
compound and distribute Positron Emission
tomography (PET)
radiopharmaceuticals for clinical trials.
The company's new services for the clinical trial market will be
discussed at the Society of ...
Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
... obstructive hydrocephalus. If a
communication larger than the diameter of a wafer exists, it should be
closed prior to wafer implantation. Computed
tomography and magnetic
resonance imaging of the head may demonstrate enhancement in the brain
tissue surrounding the resection cavity after implantation of ...
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
... (Nasdaq:
VOLC), a leading manufacturer and developer of intravascular ultrasound
(IVUS), functional measurement (FM) and Optical Coherence
tomography (OCT)
products designed to enhance the diagnosis and treatment of coronary and
peripheral vascular disease, announced today participation in SATURN ...
Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
... of rimonabant on several features of HDL and
on a comprehensive set of cardiometabolic markers. Furthermore, an imaging
substudy using computed
tomography was conducted to test, for the first
time, the hypothesis that rimonabant could induce a loss of visceral fat
and liver fat.
"We know that the most ...
Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
... The study results were gathered from 60 patients receiving Lucentis
therapy for wet AMD. Patients were monitored monthly using optical
coherence
tomography (OCT) and fluorescein angiography. When subretinal
fluid from leaking vessels was detected by OCT, patients were re-injected
with Lucentis. 30 ...
Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
... Sidec's First Protein Tomography
Symposium at the fourth annual PEGS Summit 28 April - 2 May at the
Intercontinental Hotel in Boston.
With Protein
tomography it is possible to study the molecular mode of
action of individual molecules in situ and in vitro. The unique biological
information obtained can ...
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
... in patients treated
with GAMMAGARD S/D and GAMMAGARD LIQUID compared to those who received
placebo based on 18F-fluoro-deoxyglucose Positron Emission
tomography (PET)
(FDG-PET) scans, which are sometimes used in the diagnosis of Alzheimer's
disease. Across brain regions usually affected by Alzheimer's ...
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
... the
dopamine transporter (DAT) protein found on the surface of
dopamine-producing neurons, making it visible during Single Photon Emission
Computed
tomography or "SPECT" imaging. Since most forms of Parkinsonian
Syndromes result in a decreased number of dopamine-producing cells, it
would be expected that ...
PAREXEL Expands Global Clinical Pharmacology Capabilities
... and oncology studies, and provides leading offerings such as
advanced neuroimaging and radiochemistry capabilities using Positron
Emission
tomography (PET).
The PAREXEL Clinical Pharmacology Research Unit in London, established
more than 15 years ago, has been expanded to a 64-bed capacity. The ...
FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
... March 19 /PRNewswire/ -- FluoroPharma Inc., a company
developing breakthrough cardiovascular molecular imaging agents for the
Positron Emission
tomography (PET) market, announced commencement of Phase
I clinical trials for BFPET, following institutional review board (IRB)
approval of the proposed ...
FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
... March 3 /PRNewswire/ -- FluoroPharma Inc., a company developing
breakthrough cardiovascular molecular imaging agents for the Positron
Emission
tomography (PET) market, announced positive Phase I safety results
for CardioPET, the company's lead product.
The trial was designed to evaluate safety, ...
ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
... The study results were gathered from 60 patients receiving Lucentis
therapy for wet AMD. Patients were monitored monthly using optical
coherence
tomography (OCT) and fluorescein angiography. When leakage from
vessels was detected, patients were re-injected with Lucentis. 30 patients
received Xibrom dosed ...
VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
... of cardiovascular disease, announced today that
it has enrolled the first patient in its Phase 2 clinical trial that
utilizes Positron Emission
tomography with fluorodeoxyglucose tracer
(FDG-PET) to measure VIA-2291's ability to reduce vascular inflammation in
treated patients. The company also provided ...
Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
... the
dopamine transporter (DAT) protein found on the surface of
dopamine-producing neurons, making it visible during Single Photon Emission
Computed
tomography or "SPECT" imaging. Since most forms of Parkinsonian
Syndromes result in a decreased number of dopamine-producing cells, it
would be expected that ...
PET Scans Show Gene Therapy Normalizes Brain Function in Parkinson's Patients
... motor network. The investigators were not expecting to see
changes in cognition, and the scans confirmed that this did not occur.
Position emission
tomography (PET) scans were performed before the
surgery and repeated six months later and then again one year after the
surgery. The motor network on the ...
Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
... Imaging Diagnostic Systems is currently collecting data from clinical
sites for the future filing of an FDA Premarket Approval (PMA) for the
Computed
tomography Laser Mammography (CTLM(R)) system to be used as an
adjunct to mammography. The FDA has determined that the Company's clinical
study is a ...
ACRIN Study Endorses Virtual Colonoscopy - Validation for Colon CAD Software Maker Medicsight plc
... PLC is a medical imaging software
development company developing enterprise-wide Computer-Aided Detection
(CAD) software which analyses computer
tomography (CT) scans for the early
detection and measurement of colorectal polyps and lung lesions. Medicsight
has focused on two of the leading causes of ...